My bookmarksSign up free

98/393/EC: Commission Decision of 19 May 1998 on financial… ANNEX

98/393/EC: Commission Decision of 19 May 1998 on financial… ANNEX

ANNEXSupplementary provisions

Financial information related to the storage of antigen for production of foot-and-mouth disease vaccine STATEMENT OF COSTS >START OF GRAPHIC> Reporting period from to Reference No of Commission Decision providing financial assistance: Name and address of beneficiary: Category of costs Amount for the period (National currency) (1) 1. Staff 2. Capital equipment 3. Consumables 4. Insurance 5. Rental of premises Total (1) All costs must be expressed in national currency. Certificate by the beneficiary We certify that: - the above costs were incurred in connection with the tasks defined in the Decision and were essential to the sound performance of those tasks, - they are genuine costs falling within the definition of reimbursable costs, - all the documents supporting the costs are available for audit purposes. Date: Name of technical director: Signature: Date: Person financially responsible: Signature: >END OF GRAPHIC>

Read the full instrument →

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX of 98/393/EC: Commission Decision of 19 May 1998 on financial… (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next